Last updated on .
I'm currently in San Francisco, working on Harbor.
Harbor is an AI-native CRO helping medical device and biotech companies run faster, more predictable clinical trials. We are currently running a 15-site, 200-subject US study. We're a good fit for teams planning upcoming US-based feasibility, pivotal, or post-approval studies who want a more modern alternative to traditional time-and-materials CROs. Our model combines software-enabled operations with milestone-based pricing, so sponsors get better visibility into cost, timeline, and execution.